MisterBlues schreef op 20 februari 2024 10:03:
[...]
Zeer interessant en helder geschreven (leesbaar voor leken). De drie verschuivingen waar het oude artikel over rept zijn alle drie onomstotelijk waar gebleken.
1....proving that CRISPR can be used as a therapeutic platform technology in the clinic.”
2....It is anticipated that Vertex and CRISPR Therapeutics’s collaboration on the CRISPR-based sickle cell disease treatment given to Victoria Gray and other trial participants in the US and Europe will be approved this year, likely first in Europe.
3..........Prime editing, another technique for edits without double-strand breaks, is also being developed for the clinic. Different types of CRISPR proteins, and CRISPR-based epigenome editors that alter how much protein is made from a given gene rather than changing the DNA sequence, are also being developed towards clinical use. These new technologies will expand the range of conditions that can potentially be treated using CRISPR tools.